Deutsch English Français

Contact

EP0824341

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP0824341

EP0824341 - PREVENTION OF TOOTH LOSS BY THE ADMINISTRATION OF ALENDRONATE OR ITS SALTS [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 07.02.2003 Database last updated on 03.10.2024
Most recent event Tooltip	07.02.2003	Application deemed to be withdrawn	published on 26.03.2003 [2003/13]
Applicant(s)	For all designated states Merck & Co., Inc. 126 East Lincoln Avenue Rahway, New Jersey 07065 / US
	[N/P]
Former [1998/09]	For all designated states MERCK & CO., INC. 126 East Lincoln Avenue Rahway, New Jersey 07065 / US
Inventor(s)	01 / YATES, Ashley, J. 126 East Lincoln Avenue Rahway, NJ 07065 / US
	02 / KARPF, David, B. 126 East Lincoln Avenue Rahway, NJ 07065 / US
	[1998/09]
Representative(s)	Hiscock, Ian James, et al European Patent Department, Merck & Co., Inc., Terlings Park, Eastwick Road Harlow, Essex CM20 2QR / GB
	[N/P]
Former [1998/09]	Hiscock, Ian James, et al European Patent Department, Merck & Co., Inc., Terlings Park, Eastwick Road Harlow, Essex CM20 2QR / GB
Application number, filing date	96913967.4	08.05.1996
	[1998/09]
	WO1996US06505
Priority number, date	US19950439749	12.05.1995 Original published format: US 439749
	[1998/09]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO9635407
	Date:	14.11.1996
	Language:	EN
	[1996/50]
	Type:	A1 Application with search report
	No.:	EP0824341
	Date:	25.02.1998
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 14.11.1996 takes the place of the publication of the European patent application.
	[1998/09]
Search report(s)	International search report - published on:	US	14.11.1996
	(Supplementary) European search report - dispatched on:	EP	19.05.1999
Classification	IPC:	A61K7/16, A61K31/66	[1999/24]
	CPC:	A61K31/663 (EP,US); A61K8/55 (EP,US); A61Q11/00 (EP,US)
	Former IPC [1998/09]	A61K7/16
Designated contracting states	AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, NL, PT, SE [1998/09]
Title	German:	VORBEUGUNG GEGEN ZAHNVERLUST DURCH VERABREICHUNG VON ALENDRONAT ODER DESSEN SALZE	[1998/09]
	English:	PREVENTION OF TOOTH LOSS BY THE ADMINISTRATION OF ALENDRONATE OR ITS SALTS	[1998/09]
	French:	PREVENTION DES PERTES DE DNETS PAR L'ADMINISTRATION D'ALENDRONATE OU DE SES SELS	[1998/09]
Entry into regional phase	12.12.1997	National basic fee paid
	12.12.1997	Search fee paid
	12.12.1997	Designation fee(s) paid
	12.12.1997	Examination fee paid
Examination procedure	11.12.1996	Request for preliminary examination filed International Preliminary Examining Authority: US
	12.12.1997	Examination requested [1998/09]
	06.05.2002	Despatch of a communication from the examining division (Time limit: M04)
	17.09.2002	Application deemed to be withdrawn, date of legal effect [2003/13]
	23.10.2002	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2003/13]
Fees paid	Renewal fee
	02.06.1998	Renewal fee patent year 03
	31.05.1999	Renewal fee patent year 04
	31.05.2000	Renewal fee patent year 05
	31.05.2001	Renewal fee patent year 06
	Penalty fee
	Additional fee for renewal fee
	31.05.2002	07 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[Y]EP0449405 (MERCK & CO INC [US]) [Y] 1-9* page 4, lines 31-32; example 1 *;
		[DX]US5270365 (GERTZ BARRY J [US], et al) [DX] 1-9 * claims 1,4,9 *;
		[X]WO9414455 (MERCK & CO INC [US], et al) [X] 1-9 * page 9, lines 6-16; claims 1,2,15 *;
		[Y]WO9421266 (LEIRAS OY [FI]) [Y] 1-9 * page 2, line 36 - page 3, line 9; claims 9,10 *;
		[PX]WO9528145 (PROCTER & GAMBLE [US]) [PX] 1-9 * example 4; claim - *;
		[E]WO9729754 (BINDERMAN ITZHAK [IL], et al) [E] 1-9 * claim - *;
		[PX] - YAFFE A ET AL, "THE EFFECT OF BISPHOSPHONATE ON ALVEOLAR BONE RESORPTION FOLLOWING MUCOPERIOSTEAL FLAP SURGERY IN THE MANDIBLE OF RATS", JOURNAL OF PERIODONTOLOGY, (199511), vol. 66, no. 11, pages 999 - 1003, XP000653815 [PX] 1-9 * the whole document *
		[X] - WEINREB M, "Histomorphometrical analysis of the effects of the bisphosphonate alendronate on bone loss caused by experimental periodontitis in monkeys", J. PERIODONT. RES., (1994), vol. 29, no. 1, pages 35 - 40, XP002100775 [X] 1-9 * the whole document * DOI: http://dx.doi.org/10.1111/j.1600-0765.1994.tb01088.x
		[X] - BRUNSWALD M. A., "Effects of a bisphosphonate on experimental periodontitis in monkeys", J. PERIODONTOL., (1992), vol. 63, no. 10, pages 825 - 830, XP002100776 [X] 1-9 * the whole document *
		[X] - IGARASHI K, "Anchorage and retentive effects of a bisphosphonate (AHBuBP) on tooth movements in rats", AM. J. ORTHODONT. DENTOFAC. OTHOPED., (1994), vol. 106, no. 3, pages 279 - 289, XP002100777 [X] 1-9 * the whole document *
		[X] - REDDY M.S., "Alendronate treatment of naturally-occurring periodontitis in Beagle dogs", J, PERIODONTOL., (199503), vol. 66, no. 3, pages 211 - 217, XP002100778 [X] 1-9 * the whole document *
	International search	[A]US4621077 (ROSINI SERGIO [IT], et al);
		[Y]US5270365 (GERTZ BARRY J [US], et al);
		[A]US5366965 (STREIN KLAUS [DE]);
		[AP]US5431920 (BECHARD SIMON R [CA]);
		[AP]US5462932 (BRENNER GERALD S [US], et al)

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p